|
Vaccine Detail
Neuroblastoma DNA vaccine HuDsec |
Vaccine Information |
- Vaccine Name: Neuroblastoma DNA vaccine HuDsec
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0004444
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- HuD
gene engineering:
- Type: DNA vaccine construction
- Description: Vector pcDNA 3.1 expressed Hu proteins which are the human homologues of the Drosophila protein elav, including HuD (Carpentier et al., 1998).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000132
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Efficacy: Immunized animals were challenged by s.c. implantation of a neuroblastoma cell line that constitutively expresses HuD. When compared with controls, mice immunized with the secreted HuD showed significant tumor growth inhibition (51% reduction volume; P = 0.0012), and 14% of them had complete tumor rejection (Carpentier et al., 1998).
|
References |
Carpentier et al., 1998: Carpentier AF, Rosenfeld MR, Delattre JY, Whalen RG, Posner JB, Dalmau J. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998; 4(11); 2819-2824. [PubMed: 9829748].
|
|